Recruiting studies: Vte Prophylaxis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis
Phase 4 · 1 location(s) · Science Valley Research Institute · NCT06958588 Excretion of Rivaroxaban in Human Breast Milk
Phase 1 · 1 location(s) · Thomas Jefferson University · NCT06831474 VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy
Phase 2/Phase 3 · 1 location(s) · Ottawa Hospital Research Institute · NCT05920343 Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
Phase 4 · 1 location(s) · Ottawa Hospital Research Institute · NCT06603870 A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery
Phase N/A · 1 location(s) · RenJi Hospital · NCT06259149 DOAC - Dosing Options in AntiCoagulation Prophylaxis
Phase 3 · 1 location(s) · University of Vermont · NCT07005024 Prediction of Venous Thrombosis During chemotherapy-the PINPOINT Study
Phase N/A · 3 location(s) · University of Dublin, Trinity College · NCT07196020 REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Particip
Phase 3 · 32 location(s) · Regeneron Pharmaceuticals · NCT07213778 PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
Phase 3 · 12 location(s) · Sunnybrook Health Sciences Centre · NCT03559114 Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Canc
Phase 3 · 2 location(s) · Regeneron Pharmaceuticals · NCT07493304 Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty
Phase 2 · 1 location(s) · Livzon Pharmaceutical Group Inc. · NCT06963320 Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is
Phase 3 · 18 location(s) · Regeneron Pharmaceuticals · NCT07430956 Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eA
NA · 1 location(s) · Brigham and Women's Hospital · NCT03728166 Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk
Phase 4 · 18 location(s) · University Hospital, Brest · NCT06845423 REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Phase 3 · 46 location(s) · Regeneron Pharmaceuticals · NCT07015905 REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Phase 3 · 13 location(s) · Regeneron Pharmaceuticals · NCT07410117

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.